Biosimilars - GEN - Genetic Engineering and Biotechnology News

Quality Control Laboratory medicine. Chromatograph operation. A woman makes an analysis on a gas chromatograph. Development of a new vaccine against the covid-19 virus

Biosimilars

Employing a Connected, Integrated Alternative to Continuous Bioprocessing

Drug Discovery

Biogen Poised for Pipeline Growth, Samsung Eyes New Drug Expansion after $2.3B Joint Venture Deal

Bioreactor

Biosimilars

End-to-End Continuous Processing is Technically Possible

Covid-19 vaccine production line.

Biosimilars

Biopharma Investment in Process Intensification about More than Cost

Lab technician

Biosimilars

Optimizing a Continuous Bioprocess with a Digital Twin

Biosimilars

Almac Group Expands Analytical Solutions to Include Biologics Testing

Virtual Reality Conference

GENcast

Digital Tools Push Single-Use Technology Challenges to the Side

Abstract network

GENcast

Virtual Collaborations Push Pharma Forward During Pandemic

Concept of SARS-CoV-2 or 2019-ncov coronavirus

GENcast

Impact of COVID-19 on the Life Science Industry

Scientist Interacting With The Computer Via Touch Screen

GENcast

Trends in Bioprocess 4.0 and their Impact on Biomanufacturing

ImmunoglobulinG Antibody Molecule

GENcast

Helping Biosimilars Emerge into Global Markets Takes a Practiced Hand

Glycosylation enzyme molecule

Biosimilars

Applying the Bioprocessing 4.0 Paradigm to Antibody Glycosylation

Biosimilars

Biogen Raising Minority Stake in Samsung Bioepis in $672M Deal

White pill with red capsule in the middle

Biosimilars

Managing Biosimilars Is Like Herding Copycats

Biosimilars

The Impact of Biosimilars on the Biopharmaceuticals Industry

12 3...9 Page 1 of 9